Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Tioga Pharmaceuticals Announces Initiation of Phase 2 Clinical Study of Asimadoline in Patients with Pruritus Associated
SAN DIEGO - Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study... Read more
Profound Medical Corp. Announces Closing of Qualifying Transaction
TORONTO, June 5, 2015 (GLOBE NEWSWIRE) -- Profound Medical Corp. (the "Company") (TSXV:PRN), formerly Mira IV Acquisition Corp. (TSXV:MRY-P.V), announced... Read more